Skip to main content

US ClosedU.S. Closed

MXCT: MaxCyte, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

MaxCyte, Inc. , a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

52W Range

47thpctl

Volume

0.52×avg

Market Cap

130.69MUSD

P/E Ratio

-3.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

MaxCyte, Inc.

MXCTNASDAQ·USD·Closed

MaxCyte, Inc.

MXCTNASDAQ·USD·Closed

$1.22

−4.69%

$1.22

−$0.06 (4.69%)

52W Range

47thpctl

Volume

0.52×avg

Mkt Cap

130.69MUSD

P/E

-3.6TTM

Div Yield

–ann